A clinical case of multisystem inflammatory syndrome
https://doi.org/10.25789/YMJ.2023.82.33
Abstract
The article presents a clinical case of children multisystem inflammatory syndrome (MIS-C) associated with a new coronavirus infection (COVID-19) in a 10-year-old child complicated by pancarditis: endomyopericarditis, unspecified bronchopneumonia, systemic inflammatory response syndrome of infectious origin with an organic disorder: with a lesion heart, kidney, liver, multiple organ failure, secondary antiphospholipid syndrome. The correspondence of the clinical picture, laboratory and instrumental data to the diagnosis of MIS-C, and differential diagnosis are discussed.
About the Authors
M. S. Savvina
FGBNU YANC KMP
Russian Federation
Russian Federation
Yakutsk
V. M. Argunova
Pediatric Center of GAU RS (Ya) "RB No. 1-NCM
Russian Federation
Russian Federation
Yakutsk
T. E. Burtseva
MI NEFU named after M.K. Ammosov
Russian Federation
Russian Federation
Yakutsk
V. B. Egorova
MI NEFU named after M.K. Ammosov
Russian Federation
Russian Federation
Yakutsk
V. P. Shadrin
MI NEFU named after M.K. Ammosov
Russian Federation
Russian Federation
Yakutsk
A. A. Yakovlev
SPbGPMU
Russian Federation
Russian Federation
Saint-Petersburg
References
1. Kostik M.M. Cardiac involvement in multisystem inflammatory syndrome associated with COVID-19 in children: retrospective data from a multicenter cohort / M.M. Kostik et al. // Front. Pediatr. 2022. doi: 10:829420.
2. Multisystem inflammatory syndrome in children (clinical observation) / Savvina M.S. et al. // Yakut Medical Journal. 2022. No. 2. P. 131-133. doi: 10/25789/YMJ.2022.78.35.
3. Pediatric multisystem inflammatory syndrome associated with novel coronavirus infection: unsolved problems /Lobzin Yu.V. et al. // Journal of Infectology. 2021. No. 1. P. 13-20. DOI: 10.22625/2072-6732-13-1-13-20.
4. Development of preliminary differential criteria for multisystem inflammatory syndrome in children associated with COVID-19 and Kawasaki disease / Avrusin I.S. et al. // Forcipe. 2021.Vol. 4. 11-12 p.
5. A new definition for multisystem inflammatory syndrome in children / Mary Beth F. et al. // Pediatrics. 2023. 151(3). Doi: 10.1542/peds.2022-060302.
6. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe / Valverde I. et al. // Circulation. 2021. 143 (1): 21-32 p. doi: 10.1161/CIRCULATIONAHA.120.050065.
7. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic / Belhadjer Z. et al. // Circulation. 2020. 142 (5): 429-36. Doi: 10.1161/CIRCULATIONAHA.120.048360.
8. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 / Wittaker E. et al. // JAMA. 2020. 324 (3): 259-69. Doi: 10.1001/jama.2020.10369.
9. Daskalakis D. Pediatric multisystem inflammatory syndrome potentially associated with COVID-19 // NYC Health. 2020. https: //www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2020/covid-19-pediatric-multi-system-inflammatory syndrome.pdf (data available 24. 01. 2021).
10. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study / Abrams J.Y. et al. // Lancet Child Adolesc Health. 2021. 5 (5): 323-31 p. doi: 10.1016/S2352-4642(21)00050-X.
11. Hyperinflammatory shock in children during COVID-19 pandemic / Riphagen S. et al. // Lancet. 2020. 395 (10237): 1607-8. Doi: 10.1016/S0140-6736(20)31094-1.
12. Multisystem inflammatory syndrome in children : A systematic review / Ahmed, Mubbasheer, et al. // EClinicalMedicine 26 (2020): 100527. 1. 16.
13. Multisystem inflammatory syndrome in children and adults (MIS-C): case definition and guidelines for data collection, analysis, and presentation of immunization safety data / Vogel T.P. et al. // Vaccine. 2021. 39 (22): 3037-49 p. doi: 10.1016/j.vaccine.2021.01.054S0264-410X(21)00093-1.
14. Multisystem inflammatory syndrome in children (MIS-C): a mini-review / Giacalone M. et al. // International Journal of Emergency Medicine 14, 50(2021). Doi: 10.1186/s12245-021-00373-6.
15. Multisystem inflammatory syndrome in U.S. children and adolescents / Feldstein L.R. et al. // N Engl. J. Med. 2020. 383 (4): 334-6. Doi: 10.1056/NEJMoa2021680.
16. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management / Wu L. et al. // Biochem. Pharmacol. 2020. 178: 114114.
17. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic / Belay E.D. et al. // JAMA Pediatr. 2021. 175 (8): 837-45. Doi: 10.1001/jamapediatrics.2021.0630.
Review
For citations:
Savvina M.S., Argunova V.M., Burtseva T.E., Egorova V.B., Shadrin V.P., Yakovlev A.A. A clinical case of multisystem inflammatory syndrome. Yakut Medical Journal. 2023;(2):135-138. https://doi.org/10.25789/YMJ.2023.82.33
Views:
72
Email this article 